RLX030A
Laufzeit: 01.01.2014 - 31.12.2015
imported
Kurzfassung
A multicenter, randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety and tolerability in acute heart failure patients
Laufzeit: 01.01.2014 - 31.12.2015
A multicenter, randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety and tolerability in acute heart failure patients
